Bone Remodelling Markers in Rheumatoid Arthritis

Bone loss in rheumatoid arthritis (RA) patients results from chronic inflammation and can lead to osteoporosis and fractures. A few bone remodeling markers have been studied in RA witnessing bone formation (osteocalcin), serum aminoterminal propeptide of type I collagen (PINP), serum carboxyterminal propeptide of type I collagen (ICTP), bone alkaline phosphatase (BAP), osteocalcin (OC), and bone resorption: C-terminal telopeptide of type 1 collagen (I-CTX), N-terminal telopeptide of type 1 collagen (I-NTX), pyridinolines (DPD and PYD), and tartrate-resistant acid phosphatase (TRAP). Bone resorption can be seen either in periarticular bone (demineralization and erosion) or in the total skeleton (osteoporosis). Whatever the location, bone resorption results from activation of osteoclasts when the ratio between osteoprotegerin and receptor activator of nuclear factor kappa-B ligand (OPG/RANKL) is decreased under influence of various proinflammatory cytokines. Bone remodeling markers also allow physicians to evaluate the effect of drugs used in RA like biologic agents, which reduce inflammation and exert a protecting effect on bone. We will discuss in this review changes in bone markers remodeling in patients with RA treated with biologics.

• Publication year

  2014

• Venue

  Mediators of Inflammation

• Publication date

  2014-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2014/484280PMID 24839355PMCID 4009257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis

  2013cited by this paper
• Periarticular Bone Gain at Proximal Interphalangeal Joints and Changes in Bone Turnover Markers in Response to Tumor Necrosis Factor Inhibitors in Rheumatoid and Psoriatic Arthritis

  2013cited by this paper
• The effects of TNF α antagonist therapy on bone metabolism in rheumatoid arthritis: a systematic review.

  2013cited by this paper
• Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis.

  2013cited by this paper
• Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss*

  2012cited by this paper
• Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool

  2012cited by this paper
• Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis

  2012cited by this paper
• IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).

  2012cited by this paper
• Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.

  2011cited by this paper
• Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study

  2011cited by this paper
• Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis

  2010cited by this paper
• Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression

  2010cited by this paper
• Inhibition of antigen presentation and T cell costimulation blocks PTH‐induced bone loss

  2010cited by this paper
• Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlle

  2010cited by this paper
• Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study

  2010cited by this paper
• Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

  2009cited by this paper
• Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.

  2009cited by this paper
• Costimulation blockade in rheumatic diseases: where we are?

  2009cited by this paper
• Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.

  2009cited by this paper
• CTLA-4 directly inhibits osteoclast formation

  2008cited by this paper
• IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.

  2008cited by this paper
• Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis

  2008cited by this paper
• Circulating Dickkopf-1 and Radiological Progression in Patients with Early Rheumatoid Arthritis Treated with Etanercept

  2008cited by this paper
• Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

  2007cited by this paper
• A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

  2007cited by this paper
• Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists

  2007cited by this paper
• Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.

  2006cited by this paper
• Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

  2006cited by this paper
• Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.

  2006cited by this paper
• Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.

  2006cited by this paper
• Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.

  2006cited by this paper
• Bone Metabolism Changes During Anti‐TNF‐α Therapy in Patients with Active Rheumatoid Arthritis

  2006cited by this paper
• Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.

  2005cited by this paper
• RANK, RANKL and osteoprotegerin in arthritic bone loss.

  2005cited by this paper
• Comparison of dual X‐ray absorptiometry (DXA), digital X‐ray radiogrammetry (DXR), and conventional radiographs in the evaluation of osteoporosis and bone erosions in patients with rheumatoid arthritis

  2005cited by this paper
• Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment

  2005cited by this paper
• The OPG/RANKL/RANK system in metabolic bone diseases.

  2004cited by this paper
• Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers

  2004cited by this paper
• Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study.

  2004cited by this paper
• Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50–70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study

  2004cited by this paper
• Osteoclast differentiation and activation

  2003cited by this paper
• Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study.

  2003cited by this paper
• Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis

  2003cited by this paper
• Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.

  2002cited by this paper
• Bone destruction in arthritis

  2002cited by this paper
• Bone changes in early rheumatoid arthritis.

  2001cited by this paper
• Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.

  1999cited by this paper
• Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

  1999cited by this paper

• Influence of rheumatoid arthritis on peri‐implant diseases: A longitudinal retrospective clinical and radiographic evaluation

  2025influential citation
• Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study

  2025cites this paper
• Wnt signaling as a translational target in rheumatoid and psoriatic arthritis

  2025cites this paper
• OPG/RANK/RANKL Single-Nucleotide Polymorphisms in Rheumatoid Arthritis: Associations with Disease Susceptibility, Bone Mineral Density, and Clinical Manifestations in a Chinese Han Population

  2025cites this paper
• A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers

  2025cites this paper
• Proteomic Profiling Reveals Novel Molecular Insights into Dysregulated Proteins in Established Cases of Rheumatoid Arthritis

  2025cites this paper
• Relationship of immature granulocytes with disease activity in rheumatoid arthritis

  2024cites this paper
• Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel-group study.

  2024cites this paper
• White adipose tissue, a novel antirheumatic target: Clues from its secretory capability and adipectomy‐based therapy

  2024cites this paper
• Changes in Bone Metabolism in Patients with Rheumatoid Arthritis during Tumor Necrosis Factor Inhibitor Therapy

  2023cites this paper
• Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis

  2023cites this paper
• Comparing the effects of two different vitamin regimens on bone metabolism for meat ducks at starting phase

  2023cites this paper
• Correlation between anti-mutated citrullinated vimentin and bone turnover markers (CTX-1 and P1NP) in patients with rheumatoid arthritis in remission and low-disease activity

  2022cites this paper
• Modulation of Differentiation and Bone Resorbing Activity of Human (Pre-) Osteoclasts After X-Ray Exposure

  2022cites this paper
• Organokines in Rheumatoid Arthritis: A Critical Review

  2022cites this paper
• Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

  2022cites this paper
• N-MID, P1NP, β-CTX, and phosphorus in adolescents with condylar resorption.

  2022cites this paper
• Broad application prospects of bone turnover markers in pediatrics

  2022cites this paper
• Influence of Iguratimod on Bone Metabolism in Patients with Rheumatoid Arthritis: A Meta-analysis

  2022cites this paper
• Progression of vertebral bone disease in mucopolysaccharidosis VII dogs from birth to skeletal maturity.

  2021cites this paper
• Effects of 25-hydroxyvitamin D3 on growth performance, serum parameters, fecal microbiota and metabolites in weaned piglets fed diets with low calcium and phosphorus.

  2021cites this paper
• Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease

  2021cites this paper
• Polycyclic aromatic hydrocarbons in bonehomeostasis.

  2021cites this paper
• Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors

  2021cites this paper
• Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan

  2021influential citation
• Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF‐κB signalling to suppress osteoclastogenesis

  2021cites this paper
• Association Between Serum Bone Biomarker Levels and Therapeutic Response to Abatacept in Patients With Rheumatoid Arthritis (Ra): a Multicenter Ra Ultrasound Prospective Cohort Study in Japan

  2020influential citation
• Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review

  2020cites this paper
• Experimental Acute Sepsis Reduced Number of Osteocalcin Immunolabeled Cells in Periodontal Ligament.

  2020cites this paper
• Association between serum bone biomarker levels and ultrasonographic response in abatacept-treated rheumatoid arthritis patients

  2020influential citation
• Serum Pyridinoline is Associated With Radiographic Joint Erosions in Rheumatoid Arthritis.

  2019cites this paper
• Type I collagen

  2019cites this paper
• Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology

  2019cites this paper
• Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis

  2019cites this paper
• An Overview of Glucocorticoid Induced Osteoporosis-Endotext-NCBI Bookshelf

  2019cites this paper
• Composites Containing Marine Biomaterials for Bone Tissue Repair

  2019cites this paper
• IL-6: su papel en la patogenia de la artritis reumatoide. Consecuencias clínicas

  2018cites this paper
• Clinical utility of bone markers in various diseases.

  2018cites this paper
• Comparative study of anti‐VEGF Ranibizumab and Interleukin‐6 receptor antagonist Tocilizumab in Adjuvant‐induced Arthritis

  2018cites this paper
• Biologic treatment in comparison to methotrexate has positive effect on trabecular bone score in rheumatoid arthritis patients: 1-year follow-up

  2018cites this paper
• Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development

  2018cites this paper
• Association Between Vitamin D and Carboxy-Terminal Cross-Linked Telopeptide of Type I Collagen in Children During Growth Hormone Replacement Therapy.

  2018cites this paper
• Early sclerostin expression explains bone formation inhibition before arthritis onset in the rat adjuvant-induced arthritis model

  2018cites this paper
• Peroxisome proliferator‐activated receptor &ggr; plays dual roles on experimental periodontitis in rats

  2018cites this paper
• Effects of Three Corticosteroids on Equine Articular Cocultures In Vitro

  2018cites this paper
• Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody

  2017cites this paper
• Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.

  2017cites this paper
• Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis

  2017cites this paper
• RIG-I-Like Receptor Signaling in Singleton-Merten Syndrome

  2017cites this paper
• Association of self-reported symptoms with serum levels of vitamin D and multivariate cytokine profile in healthy women

  2017cites this paper
• Cytokines during periodontal wound healing: potential application for new therapeutic approach.

  2017cites this paper
• Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants

  2017cites this paper
• Factors affecting peri-implant fracture following locking plate for osteoporotic distal femur fractures.

  2017cites this paper
• The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis

  2017cites this paper
• JIMD Reports, Volume 36

  2017cites this paper
• Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity.

  2017cites this paper
• The Effect of Orally Administered Herbal Medicines in Collagen, LPS, CFA Induced Rheumatoid Like Arthritis Animal Model: A Systematic Review of Animal Study Articles Published in Korea after 2008

  2017cites this paper
• Identification des déterminants conduisant au passage à la voie sous-cutanée dans la polyarthrite rhumatoïde traitée par abatacept ou tocilizumab administré par voie intra-veineuse

  2017influential citation
• Role of CKIP-1 in suppression of osteoblast mediated bone repair in a collagen induced non-human primate arthritis model

  2017cites this paper
• EFFECTS OF ADALIMUMAB ON BONES DESTRUCTION/REPAIRING MARKER (CTX-I & PREPTIN) IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS

  2016cites this paper
• Bariatric Surgery: Bad to the Bone, Part 2.

  2016cites this paper
• Biologics Treatment Limits Disease Activity and Bone Metabolism in Patients with Rheumatoid Arthritis

  2016influential citation
• Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis

  2016cites this paper
• The Role of the Immune System in the Development of Osteoporosis and Fracture Risk

  2016cites this paper
• Increased risk of vertebral fracture in patients with rheumatoid arthritis

  2016cites this paper
• Bone Biomarkers Related to Osteoarthritis

  2016cites this paper
• Bariatric Surgery: Bad to the Bone, Part 1.

  2016cites this paper
• Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary Sjögren's syndrome.

  2016cites this paper
• Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.

  2016influential citation
• Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis

  2015cites this paper
• Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss.

  2015cites this paper
• Phenotypic characterization of type II collagen-induced arthritis in Wistar rats.

  2015cites this paper
• Signaling pathways in osteogenesis and osteoclastogenesis: Lessons from cranial sutures and applications to regenerative medicine

  2015cites this paper
• Protein Phosphatase 2A Mediates Oxidative Stress Induced Apoptosis in Osteoblasts

  2015cites this paper
• The role of cytokines in the pathogenesis of rheumatoid arthritis--Practical and potential application of cytokines as biomarkers and targets of personalized therapy.

  2015cites this paper
• ROMATOİD ARTRİTTE HASTALIK AKTİVİTE SKORLARI İLE KEMİK MİNERAL YOĞUNLUĞU ARASINDAKI İLİŞKİ Relationship Between Disease Activity Scores and Bone Mineral Density in Patients with Rheumatoid Arthritis

  2014cites this paper
• Autologous Adipose Derived Adult Multipotent Stromal Cells Alter the Porcine Systemic Immune and Bone Biomarkers Response to Cancellous Bone Xenografts

  2014cites this paper
• Does a biological link exist between periodontitis and rheumatoid arthritis

  2014cites this paper
• AN OVERVIEW OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS

  year unknowncites this paper